Moreover, our findings also go in line with previous studies that highlighted lncRNA XIST as an upregulated diagnostic biomarker in PBMCs of HCC patients (53) and miR-4484, miRK12-5-5p, and miR-3646 as upregulated biomarkers in nipple discharge of BC patients (54). This evidence concerns the gene XIST and breast cancer.